NCT03583632

Brief Summary

Improvement in visual acuity and retinal anatomy one year after surgery is assessed and compared to data preoperative and 3 months after surgery

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2018

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 28, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 11, 2018

Completed
5.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

March 15, 2024

Status Verified

March 1, 2024

Enrollment Period

5.9 years

First QC Date

June 28, 2018

Last Update Submit

March 13, 2024

Conditions

Epiretinal Membrane

Outcome Measures

Primary Outcomes (1)

  • visual acuity

    visual acuity testing with EDTRS charts

    3 minutes

Secondary Outcomes (1)

  • optical coherence tomography

    3 minutes

Interventions

visual acuity testingOTHER

testing of visual ycuity by ETDRS charts

optical coherence tomographyDEVICE

optical coherence tomography generates sectional slides of the retinal tomography with light

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

For this study only patients after vitrectomy with Membrane Peeling due to epiretinal membranes are selected

You may qualify if:

  • vitrectomy with Membrane Peeling due to an epiretinal membrane

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna

Vienna, 1140, Austria

Location

MeSH Terms

Conditions

Epiretinal Membrane

Interventions

Tomography, Optical Coherence

Condition Hierarchy (Ancestors)

Retinal DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

Tomography, OpticalOptical ImagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisTomographyInvestigative Techniques

Study Officials

  • Oliver Findl, MD, Prof

    VIROS at Hanuschkrankenhaus Vienna

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of the Department of Ophthalmology, Professor, Principal Investigator

Study Record Dates

First Submitted

June 28, 2018

First Posted

July 11, 2018

Study Start

February 1, 2018

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

March 15, 2024

Record last verified: 2024-03

Locations

AU(1)